The global fluorescence-guided surgery system market is poised for remarkable growth, with projections from Future Market Insights (FMI) indicating a surge to USD 110.8 million by 2024 and an impressive USD 468 million by 2034. FMI’s latest forecast suggests a robust Compound Annual Growth Rate (CAGR) of 15.5% from 2024 to 2034, underlining the sector’s significant expansion.
Driving this exponential growth trajectory are the escalating numbers of surgeries for cancer and cardiovascular diseases, necessitating the adoption of fluorescence-guided surgery systems. These innovative systems offer surgeons enhanced visualization and precision during procedures, contributing to better patient outcomes and recovery rates.
Get Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-19603
Moreover, the industry is witnessing a rapid digital transformation, propelled by cutting-edge technologies such as Artificial Intelligence (AI), Internet of Things (IoT), and blockchain. These advancements are revolutionizing surgical practices, leading to improved efficiency and personalized customer experiences.
“The future of surgery lies in the seamless integration of technology to augment clinical capabilities,” remarked a spokesperson from Future Market Insights. “The increasing adoption of fluorescence-guided surgery systems underscores the healthcare industry’s commitment to leveraging innovation for superior patient care.”
The projected surge in the fluorescence-guided surgery system market reflects a broader trend towards advanced medical solutions aimed at addressing complex healthcare challenges. As stakeholders embrace digitalization and technological innovation, the stage is set for transformative advancements in surgical practices worldwide.
Key Takeaways from the Fluorescence Guided Surgery System Market Report:
- The fluorescence-guided surgery system market is expected to reach a valuation of USD 468 million by 2034.
- The market is projected to surge at a CAGR of 15.5% by 2034.
- China’s fluorescence-guided surgery system market is expected to grow at a CAGR of 16.3% by 2034.
- The United States is projected to reach a valuation of USD 84.5 million in 2034.
- Based on type, the SPY system segment held a market share of 34% in 2023.
“Technological advancements and changing consumer preferences are set to fuel expansion in the fluorescence-guided surgery system industry. Leading companies are also projected to benefit from rising demand, favorable regulatory environments, and a growing focus on sustainability.” – says a lead analyst at Future Market Insights (FMI)
Ask for Customize Research Report: https://www.futuremarketinsights.com/customization-available/rep-gb-19603
Competitive Landscape:
Stryker Corporation, Olympus Corporation, Medtronic PLC, OnLume Inc., and Getinge AB are key fluorescence-guided surgery system manufacturers listed in the report. Leading manufacturers employ strategies such as mergers, acquisitions, partnerships, distribution agreements, collaborations, advertisements, and celebrity endorsements. This helps key companies enhance brand visibility, establish credibility, and gain a competitive advantage in the dynamic landscape.
Industry Updates,
- In 2023, Unify Medical and the Mayo Clinic partnered to develop medical devices using Unify’s fluorescence-guided visualization technology.
- In 2024, Leica Microsystems introduced an updated version of its ARveo 8 digital visualization microscope, which enhances surgical visualization in neurosurgery.
Leading Fluorescence Guided Surgery System Brands:
- Stryker Corporation
- Hamamatsu Photonics K.K.
- Olympus Corporation
- Medtronic PLC
- OnLume Inc.
- Getinge AB
- Curadel LLC
- PerkinElmer, Inc.
- Karl Storz SE & Co. KG
- Irillic Pvt. Ltd
- Shimadzu Corporation
A Full Report Analysis: https://www.futuremarketinsights.com/checkout/19603
Key Segments of Market Report:
By Type:
The industry is segregated into SPY system, PDE system, VS3 iridium system, and others.
By Surgery:
In terms of surgeries, the industry is divided into open surgery and laparoscopy/endoscopy.
By Application:
A few of the important applications include cancer surgeries, cardiovascular surgeries, and others.
By Region:
Key countries of North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, and the Middle East and Africa are covered.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
